121 related articles for article (PubMed ID: 1412713)
1. Excavations into the active-site gorge of cholinesterases.
Soreq H; Gnatt A; Loewenstein Y; Neville LF
Trends Biochem Sci; 1992 Sep; 17(9):353-8. PubMed ID: 1412713
[TBL] [Abstract][Full Text] [Related]
2. Differences in active-site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP
Chem Biol Interact; 1999 May; 119-120():61-9. PubMed ID: 10421439
[TBL] [Abstract][Full Text] [Related]
3. Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept) to cholinesterases.
Saxena A; Fedorko JM; Vinayaka CR; Medhekar R; Radić Z; Taylor P; Lockridge O; Doctor BP
Eur J Biochem; 2003 Nov; 270(22):4447-58. PubMed ID: 14622273
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the Binding of Reversible Inhibitors to Human Butyrylcholinesterase and Acetylcholinesterase: A Crystallographic, Kinetic and Calorimetric Study.
Rosenberry TL; Brazzolotto X; Macdonald IR; Wandhammer M; Trovaslet-Leroy M; Darvesh S; Nachon F
Molecules; 2017 Nov; 22(12):. PubMed ID: 29186056
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products.
Nicolet Y; Lockridge O; Masson P; Fontecilla-Camps JC; Nachon F
J Biol Chem; 2003 Oct; 278(42):41141-7. PubMed ID: 12869558
[TBL] [Abstract][Full Text] [Related]
6. Amino acid residues controlling acetylcholinesterase and butyrylcholinesterase specificity.
Vellom DC; Radić Z; Li Y; Pickering NA; Camp S; Taylor P
Biochemistry; 1993 Jan; 32(1):12-7. PubMed ID: 8418833
[TBL] [Abstract][Full Text] [Related]
7. Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP
Biochemistry; 1997 Dec; 36(48):14642-51. PubMed ID: 9398183
[TBL] [Abstract][Full Text] [Related]
8. Chimeric human cholinesterase. Identification of interaction sites responsible for recognition of acetyl- or butyrylcholinesterase-specific ligands.
Loewenstein Y; Gnatt A; Neville LF; Soreq H
J Mol Biol; 1993 Nov; 234(2):289-96. PubMed ID: 8230213
[TBL] [Abstract][Full Text] [Related]
9. Amino acid residues involved in the interaction of acetylcholinesterase and butyrylcholinesterase with the carbamates Ro 02-0683 and bambuterol, and with terbutaline.
Kovarik Z; Radić Z; Grgas B; Skrinjarić-Spoljar M; Reiner E; Simeon-Rudolf V
Biochim Biophys Acta; 1999 Aug; 1433(1-2):261-71. PubMed ID: 10446376
[TBL] [Abstract][Full Text] [Related]
10. Biochemical evaluation of photolabile precursors of choline and of carbamylcholine for potential time-resolved crystallographic studies on cholinesterases.
Peng L; Silman I; Sussman J; Goeldner M
Biochemistry; 1996 Aug; 35(33):10854-61. PubMed ID: 8718877
[TBL] [Abstract][Full Text] [Related]
11. Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitors.
Radić Z; Pickering NA; Vellom DC; Camp S; Taylor P
Biochemistry; 1993 Nov; 32(45):12074-84. PubMed ID: 8218285
[TBL] [Abstract][Full Text] [Related]
12. Reversible inhibition of acetylcholinesterase and butyrylcholinesterase by 4,4'-bipyridine and by a coumarin derivative.
Simeon-Rudolf V; Kovarik Z; Radić Z; Reiner E
Chem Biol Interact; 1999 May; 119-120():119-28. PubMed ID: 10421445
[TBL] [Abstract][Full Text] [Related]
13. Active site gating and substrate specificity of butyrylcholinesterase and acetylcholinesterase: insights from molecular dynamics simulations.
Fang L; Pan Y; Muzyka JL; Zhan CG
J Phys Chem B; 2011 Jul; 115(27):8797-805. PubMed ID: 21682268
[TBL] [Abstract][Full Text] [Related]
14. Does "butyrylization" of acetylcholinesterase through substitution of the six divergent aromatic amino acids in the active center gorge generate an enzyme mimic of butyrylcholinesterase?
Kaplan D; Ordentlich A; Barak D; Ariel N; Kronman C; Velan B; Shafferman A
Biochemistry; 2001 Jun; 40(25):7433-45. PubMed ID: 11412096
[TBL] [Abstract][Full Text] [Related]
15. Structure and functions of acetylcholinesterase and butyrylcholinesterase.
Massoulié J; Sussman J; Bon S; Silman I
Prog Brain Res; 1993; 98():139-46. PubMed ID: 8248501
[No Abstract] [Full Text] [Related]
16. Acetylcholinesterase active centre and gorge conformations analysed by combinatorial mutations and enantiomeric phosphonates.
Kovarik Z; Radić Z; Berman HA; Simeon-Rudolf V; Reiner E; Taylor P
Biochem J; 2003 Jul; 373(Pt 1):33-40. PubMed ID: 12665427
[TBL] [Abstract][Full Text] [Related]
17. Conversion of acetylcholinesterase to butyrylcholinesterase: modeling and mutagenesis.
Harel M; Sussman JL; Krejci E; Bon S; Chanal P; Massoulié J; Silman I
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10827-31. PubMed ID: 1438284
[TBL] [Abstract][Full Text] [Related]
18. Specificity and orientation of trigonal carboxyl esters and tetrahedral alkylphosphonyl esters in cholinesterases.
Hosea NA; Berman HA; Taylor P
Biochemistry; 1995 Sep; 34(36):11528-36. PubMed ID: 7547883
[TBL] [Abstract][Full Text] [Related]
19. Acetylcholinesterase and butyrylcholinesterase expression in adult rabbit tissues and during development.
Jbilo O; L'Hermite Y; Talesa V; Toutant JP; Chatonnet A
Eur J Biochem; 1994 Oct; 225(1):115-24. PubMed ID: 7925428
[TBL] [Abstract][Full Text] [Related]
20. New potent acetylcholinesterase inhibitors in the tetracyclic triterpene series.
Sauvaître T; Barlier M; Herlem D; Gresh N; Chiaroni A; Guenard D; Guillou C
J Med Chem; 2007 Nov; 50(22):5311-23. PubMed ID: 17902635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]